L
YMPHOMAS, both primary and metastatic, account for 1% to 3% of the tumors in the central nervous system (CNS). However, this incidence will probably increase due to longer survival rates from better chemotherapeutic and radiation techniques and to the increasing number of transplant recipients and patients with acquired immunodeficiency syndrome (AIDS). The term "signet-ring cell lymphoma" has been used to designate a rare morphological variant of nonHodgkin's lymphoma first described in 1978 by Kim, et aL, ~3 in the lymph nodes or in the mesentery of seven patients. The signet-ring cell is due to the presence of eosinophilic cytoplasmic inclusions, with a clear, vacuolated, or Russell body-like appearance, displacing the nucleus to the periphery. Markers for light and heavy immunoglobulin (Ig) chains indicate that most of the reported cases were B-cell derivations, whereas three cases expressed T-cell phenotypes. Since 1978, authors have reported this disease entity in peripheral,9.1 1.13,14,2 I retroperitoneal,16'18'20 and mesenteric lymph /lodes, 13'~6 skin, 7'8'21 tonsils, 3 thyroid, 1 salivary gland, ~9 and orbit. 4 This is the first reported case of signet-ring cell lymphoma in the CNS.
Case Report
This 64-year-old white retired salesman with a history of myocardial infarction presented for evaluation of two tonic/clonic seizures involving all extremities. He apparently lost consciousness and was amnesic with his last seizure.
Examination. Physical examination demonstrated no focal neurological deficits. A computerized tomography (CT) scan revealed a contrast-enhanced lobulated fight frontal lobe mass with a large amount of surrounding edema, possibly invading the corpus callosum and right caudate nucleus (Fig. 1) . Selective right internal carotid arteriograms demonstrated a shift of the anterior cerebral artery to the left and caudally. The sylvian triangle was displaced inferiorly with tumor vessels visualized with some puddling and early medullary draining veins.
Operation. The patient underwent right frontal craniotomy for subtotal removal. The gray-tan tumor was firm but suctionable.
Pathological Examination. Light microscopy demonstrated a diffuse tumor growth pattern and a moderate perivascular desmoplastic response induced by the tumor. The tumor cells tended to grow in an angiocentric fashion, and this pattern was particularly evident at the edges of the lesion where perivascular infiltrates permeated the adjacent gliotic and edematous brain. Electron microscopy studies confirmed the presence of prominent intranuclear pseudoinclusions (Dutcher bodies). A minority of cells had distended cisternae of rough endoplasmic reticulum containing the same kind of finely granular stored proteinaceous material in the cytoplasm (Russell bodies). Figure 3 illustrates a representative tumor cell with abundant cytoplasmic stacks of rough endoplasmic reticulum representing the most conspicuous feature (after the intranuclear pseudoinclusion) of the tumor cell.
Postoperative Course. A search for lymphoma throughout the patient's body was performed, including bone marrow biopsy and aspiration and abdominal CT. The findings were negative, indicating an apparent primary CNS lymphoma. The patient was treated with phenobarbital and received 4140 external rads to the whole brain via 23 treatments of 180 rads each, over a total duration of 31 days, with a 1980-rad boost to the tumor area. His total dose was given via 34 treatments of 180 rads each, over a total duration of 46 days. resection and/or encephalomalacia. Presently, the patient is neurologically stable. His speech is still hesitant and at times he has difficulty in walking, although he has no focal weaknesses.
Discussion
Central nervous system lymphomas are recently drawing more attention because of an increase in the number of patients with immunosuppression from organ transplantations and immunodeficiency such as in AIDS, and the extended longevity of patients with lymphoma. With improved diagnostic methods in neuroradiology and immunocytochemistry, this disease is being studied further.
Primary lymphomas in the CNS comprise 0.7% to 1.6% of the total lymphomas reported. 6' 1~ Lymphoma presently represents 1% of all primary intracranial neoplasms. The peak age incidence is 55 to 65 years old, and there is a male predominance of 2:1. in the brain as well as in extraneural sites may manifest multifocal disease rather than metastatic disease. Some patients may develop extraneural lymphoma as a result of spread from the CNS. The mean postoperative survival rates of patients with lymphomas treated by surgery alone in past series range from 1.4 to 4.6 months. 25~~ Past series using radiotherapy report mean survival times of 11.7 to 45 months. ~~ There are 27 cases in the literature of signet-ring cell lymphoma, but none previous to this report were found in the CNS. This disease entity must be suspected on histological grounds and confirmed by immunocytochemical and ultrastructural studies. Mucinous adenocarcinoma, liposarcoma, and amelanotic melanoma should be differentiated from signet-ring cell lymphoma because of the different treatments and expected longevity involved. Although it is too early to state with any definitive accuracy the prognosis of this specific lymphoma, two reported patients with extracranial signet-ring cell l y m p h o m a have lived 720 and 9 years. ~9 The patient presented here has been stable now for over 2 years, again indicating the potential of this disease for being less malignant in nature than other primary lymphomas.
This tumor has small indented follicular cells in a nodular and diffuse pattern. The Russell body inclusions found to be displacing the nuclei peripherally can contain IgM, indicating apparent B-cell derivation. These inclusions show homogeneous, slightly electrondense material within distended rough endoplasmic reticulum. It can be postulated that the vacuoles are either a collection of abnormal proteins or the result of a basic defect in Ig transport and secretion from the cell. Immunocytochemical staining of the vacuoles gives evidence that m a n y of the vacuoles are formed by the accumulation of cytoplasmic Ig without Ig transport or secretion.
Navas-Palacios, et al., ~6 have classified signet-ring cell lymphomas into three subtypes: Type I has Russell bodies, distended loops of endoplasmic reticulum, and is positive for IgM; Type II has clear cytoplasmic vacuoles and is positive for IgG; and the third type is illdefined and corresponds to n o n m e m b r a n e -b o u n d cytoplasmic accumulation of granular, fibriUary, and crystalline material. 16 Variations and combinations of the subtypes of this classification have been reported. Our case fits into the first subtype.
In summary, signet-ring cell l y m p h o m a is a rare variant of l y m p h o m a that can be either B cell or T cell. This is the first described CNS case of B-cell signet-ring cell l y m p h o m a with Dutcher and Russell bodies, signetring cell nuclei, inclusions, and IgM positivity. No definitive prognostic characteristics have been elucidated as yet. Since a negative work-up was performed to rule out metastasis in this case, the t u m o r was apparently a primary CNS l y m p h o m a rather than a l y m p h o m a of nodal tissue. This would be similar to the primary signet-ring cell l y m p h o m a of the thyroid gland reported by Allevato, et al. 
